Literature DB >> 9496471

Effect of hypobaria on ventilatory and CO2 responses to short-term hypoxic exposure in cats.

C O Borel1, J Guy, U Barcik, M J Natoli, R D Vann.   

Abstract

The effect of hypobaria on the ventilatory response to short-term hypoxia was studied by comparing the respiratory mechanical and inspired CO2 ventilatory responses to hypobaric hypoxia (438 mmHg) with normobaric hypoxia (11.8% FIO2). Fifteen spontaneously breathing, anesthetized cats were divided into three groups of five: time control, normobaric hypoxia and hypobaric hypoxia. Measurements of ventilation, gas exchange, and responses to intermittent CO2 rebreathing were collected over a 4 h period. PaO2 fell to 44.5 +/- 2.7 mmHg, PaCO2 fell to 24.8 +/- 0.9, and pH rose to 7.49 +/- 0.01 in both hypoxic groups. Tidal volume did not change with respect to time or condition, but frequency and ventilation were significantly increased in the hypobaric hypoxic group. The slope of the CO2 response was unchanged over time or by condition. These results suggest that hypobaric hypoxia may alter the pattern of breathing responses to hypoxia but not the CO2-response. If metabolic rate remained constant, these results could be explained by a difference in dead space between hypoxic conditions.

Entities:  

Keywords:  Non-programmatic

Mesh:

Substances:

Year:  1998        PMID: 9496471     DOI: 10.1016/s0034-5687(97)00098-4

Source DB:  PubMed          Journal:  Respir Physiol        ISSN: 0034-5687


  2 in total

1.  Cytochrome P450 enzyme-mediated drug metabolism at exposure to acute hypoxia (corresponding to an altitude of 4,500 m).

Authors:  Michael Streit; Christoph Göggelmann; Christoph Dehnert; Jürgen Burhenne; Klaus-Dieter Riedel; Elmar Menold; Gerd Mikus; Peter Bärtsch; Walter E Haefeli
Journal:  Eur J Clin Pharmacol       Date:  2005-02-04       Impact factor: 2.953

2.  Use of high frequency oscillatory ventilation (HFOV) in neurocritical care patients.

Authors:  Stacey S Bennett; Carmelo Graffagnino; Cecil O Borel; Michael L James
Journal:  Neurocrit Care       Date:  2007       Impact factor: 3.210

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.